District-based startups can receive up to $10,000 in guided support to prepare competitive SBIR/STTR proposals through DSLBD’s Phase 0 Program.
Archives
Submission Perfect: How to Survive the New Intelligent SBIR/STTR Ecosystem
A new end-to-end SBIR/STTR ecosystem is raising the stakes for how smooth, compliant, and detail-perfect your grant submission must be—here’s how grant writers and funding-seeking organizations must adapt to avoid being dismissed on a “technicality.”
Preparing for the End of the Government Shutdown, What Grant Applicants Need to Do Now
Federal systems are reopening and grant seekers must prepare quickly to stay competitive as reviews, awards, and communications begin moving again.
Idaho Startups Can Get Up to $3,000 for SBIR/STTR Proposal Costs Through SBDC Phase 0 Program
Idaho startups can access $3,000 in SBIR/STTR proposal funding plus a $1,000 incentive—flexible, reimbursable, and rolling year-round.
University of Rochester Researchers Can Access SBIR/STTR Grant Writing Support
UofR researchers launching startups can access expert SBIR/STTR proposal support to strengthen their application and increase fundability.
What You Need to Know About NSF’s Indirect Cost Rate Policy (And Why It Matters)
On June 20, 2025, the U.S. District Court vacated NSF’s 15% policy (NSF 25-034), reinforcing the need for compliance.
Army Launches $6M Innovation Competition for Small Businesses
The Army is funding innovative tech from small businesses—up to $6M per award. Submit your concept white paper by June 4.
What Startups Need to Know: Federal Funding Updates
The latest on SBIR/STTR, NIH, and DoD funding trends with insights from Jameson & Company’s (an accounting company) April 2025 briefing.
How the INNOVATE Act Aims to Boost Federal Funding Access for Startups
The INNOVATE Act aims to make it easier for startups to access non-dilutive federal funding, like SBIR/STTR, by modernizing key innovation programs.
Why R&D Funding Matters More Than Ever, and How We Help
Last night’s Last Week Tonight with John Oliver took a deep dive into the devastating cuts to R&D funding — and what that means for cancer research, virus research, and the future of innovation itself, and we have some things to say about all of this.